Beta
70347

Clinical Value of Serum Fibrosis Biomarkers in Prediction of Esophageal Varices in Cirrhotic Patients

Article

Last updated: 22 Jan 2023

Subjects

-

Tags

-

Abstract

Abstract
Background: Esophageal varices is one of the major com-plications of portal hypertension, occur in approximately 30%-70% of cirrhotic patients. As portal hypertension is a consequence of liver fibrosis, serum fibrosis biomarkers could serve as non invasive predictors for esophageal varices and their grades.
Aim of Study: Determine the frequency and grading of esophageal varices in a group of cirrhotic patients with no history of upper gastrointestinal bleeding, and also evaluate and compare the predictive value of APRI, AAR, FIB-4, FI, and king scores in predicting the presence of varices and their grade.
Patients and Methods: One hundred and one cirrhotic patients were included in the study. The diagnosis of liver cirrhosis was based on clinical, laboratory and ultrasonographic data. An upper GIT endoscopic examination was performed for all patients for the diagnosis of presence or absence of esophageal varices. Serum fibrosis biomarkers were calculated from data available on the first day hospital admission and used as prognostic indicators for presence and grade of esophageal varices.
Results: Patients with esophageal varices had significantly lower mean values of platelet counts and albumin levels than those without esophageal varices (p=0.015, p=0.045; respec-tively). Also there was a significant difference between patients with and without esophageal varices as regard FI score (p= 0.016). Patients with medium to large esophageal varices had significantly lower mean values of platelet counts than those with no to mild esophageal varices. Also there was a significant difference between patients with medium to large esophageal varices and those with no to mild esophageal varices as regard FI, FI B-4 and King scores (p=0.003, p=0.001, p=0.017; respectively). The FI score was accurate in predicting presence of esophageal varices in cirrhotic patients. Using 3.52 cut-off value, a prediction of presence or absence of EV could be made in 62.4% of cirrhotic patients. FIB-4 (cut off value 3.64), FI (cut off value 3.65) and King (cut off value 26.65) scores may perform better in prediction of high grade esopha-geal varices than in prediction of presence of esophageal varices.
Conclusion: Fibrosis index prediction score at cut off value 3.52 is a moderately sensitive noninvasive tool that can predict the presence of esophageal varices in cirrhotic patients with acceptable accuracy. Thus can reduce the burden and make screening for esophageal varices less stressful for the patients. The combination of FI score (cut off value 3.64), FIB-4 score (cut off value 3.65) and King's score (cut off value 26.65) could be used as an initial screening tests to detect patients with high risk EV for whom endoscopy may be more beneficial. Hence the benefit of doing upper endoscopy overweight the burden of this maneuver.

DOI

10.21608/mjcu.2019.70347

Keywords

Esophageal varices, Serum fibrosis biomarkers, Liver cirrhosis

Authors

First Name

GHADA M. GALAL, M.D.;

Last Name

SAFAA KHALAF, M.D.

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

MARIUM

Last Name

AMIR, M.Sc.

MiddleName

-

Affiliation

The Department of Tropical Medicine and Gastroentrology, Faculty of Medicine, Sohag University

Email

-

City

-

Orcid

-

Volume

87

Article Issue

September

Related Issue

8905

Issue Date

2019-09-01

Receive Date

2019-02-06

Publish Date

2019-09-01

Page Start

3,953

Page End

3,960

Print ISSN

0045-3803

Online ISSN

2536-9806

Link

https://mjcu.journals.ekb.eg/article_70347.html

Detail API

https://mjcu.journals.ekb.eg/service?article_code=70347

Order

148

Type

Original Article

Type Code

263

Publication Type

Journal

Publication Title

The Medical Journal of Cairo University

Publication Link

https://mjcu.journals.ekb.eg/

MainTitle

-

Details

Type

Article

Created At

22 Jan 2023